Published July 24. 2021 1:57AM Riley Griffin, Bloomberg Pfizer Inc. and BioNTech SE will supply the U.S. with another 200 million doses of their COVID-19 shot, setting up a stream of vaccine deliveries through next April in a push to protect kids and potentially provide boosters. The White House is setting its sights on immunizing children under the age of 12, who aren’t yet eligible, and potentially deploying booster doses if new data show their necessity, according to a Biden administration official familiar with the contract. Of the new doses, 65 million will be tailored for the pediatric population, should the vaccine be cleared for kids younger than 12, according to the official, who spoke under the condition of anonymity as the contract isn’t public. Some of those shots would be immediately available upon authorization.